136 results
Page 4 of 7
S-3ASR
EX-5.2
81c1 s1plci22m6m2
18 May 21
Automatic shelf registration
6:01am
S-3ASR
mur6y
18 May 21
Automatic shelf registration
6:01am
S-3ASR
EX-23.1
wdo5vdj69s1zmoa5
18 May 21
Automatic shelf registration
6:01am
8-K
EX-99.2
80py8a
22 Mar 21
Akero Announces Positive Histological Improvements in Cirrhotic NASH (F4) Patients after 16 Weeks in Extension Cohort C
4:05pm
S-8
EX-5.1
93bhd
18 Mar 21
Registration of securities for employees
4:53pm
S-8
pn7i77l
18 Mar 21
Registration of securities for employees
4:53pm
S-8
EX-23.1
8ejl2jy21y 0ocjps5
18 Mar 21
Registration of securities for employees
4:53pm
8-K
EX-3.1
s4s3sn8g9z1j
12 Mar 21
Amendments to Articles of Incorporation or Bylaws
5:25pm
8-K
EX-99.1
rjhul3e zffo
11 Jan 21
A Global Disease, A Pioneering Treatment Akero Therapeutics, Inc. JP Morgan Presentation January 2021
7:01am
8-K
EX-99.1
p19s4moxfkopsj7
16 Nov 20
A Global Disease, A Pioneering Treatment Akero Therapeutics, Inc. Corporate Presentation November 2020
6:30am
8-K
EX-99.1
tbbk5jrnoqq4js5so61n
15 Oct 20
A Global Disease, A Pioneering Treatment Akero Therapeutics, Inc. Corporate Presentation October 2020
8:30am
424B4
9z74z ya454qqel15p
8 Jul 20
Prospectus supplement with pricing info
8:30pm
S-1MEF
EX-5.1
hblh6t8
7 Jul 20
Registration of additional securities for an S-1
7:27pm
S-1MEF
EX-23.1
k7s01pr
7 Jul 20
Registration of additional securities for an S-1
7:27pm